Tech Company Financing Transactions
GreenLight Biosciences Funding Round
GreenLight Biosciences, based in Medford, received $17 million in investment from Baird Capital, Flu Lab and Xeraya Capital.
Transaction Overview
Company Name
Announced On
5/13/2020
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Undisclosed
Investors
Proceeds Purpose
With this latest round of funding, GreenLight is accelerating the research and development of its fully integrated mRNA production capability and product platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Boston Ave. 1000
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Email Address
Overview
At GreenLight we develop clean biochemical processes through our proprietary Cell Free BioProcess technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrey Zarur
Chief Financial Officer
Susan Keefe
Chief Operating Officer
Carole Cobb
VP - Bus. Development
Mick Messman
VP - Bus. Development
Marta Ortega-Valle
Browse more venture capital transactions:
Prev: 5/13/2020: IntelliBoard venture capital transaction
Next: 5/13/2020: Fresh Prep venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs